Therapeutics · Hormonal Agents

Natural progesterone and antihypertensive action

Rylance PB, Brincat M, Lafferty K, De Trafford JC, Brincat S, Parsons V, Studd JW

Published January 5, 1985 British Medical Journal (Clinical Research Ed.), 290(6461), 13-14
DOI 10.1136/bmj.290.6461.13 PMID 3917316 PMC PMC1415335

RRM Academy Synopsis

Blood pressure fell on natural progesterone in a pilot trial

Blood pressure fell on natural progesterone in a pilot trial of ten adults. The 1985 double blind, placebo controlled crossover study enrolled men and postmenopausal women with mild to moderate hypertension: six men and four women finished. Lying down, their blood pressure on progesterone was significantly lower than before treatment at all three dose steps.

Key Findings

  • Twelve people enrolled (eight men, four postmenopausal women). Two men withdrew, leaving six men and four women. Nine of the twelve had stopped antihypertensive drugs four weeks before entry.
  • Supine (lying) blood pressure was significantly lower with all three progesterone dose steps than before treatment. Placebo readings at all three doses did not differ significantly from readings before treatment.
  • Supine pressure was lower on progesterone than on placebo at each dose step. Only supine diastolic pressure at the lowest step and mean arterial pressure at the middle step reached significance.
  • At the highest dose step, erect (standing) diastolic and mean arterial pressures were significantly lower on progesterone than on placebo. Pulse rate and weight showed no significant change.
  • Two men felt slightly light headed roughly an hour after taking the two higher doses.

Interpretation

The study is a randomized, double blind, placebo controlled crossover pilot study. Participants took progesterone and placebo in alternating two-week periods at three rising dose steps. Each person therefore served as their own comparison. The ten participants who completed the trial were men and postmenopausal women with hypertension that was mild to moderate. The outcomes were blood pressure, pulse rate and weight. The authors call the work a pilot and report that standing pressure fell less predictably than lying pressure.

RRM Context

Progesterone concentrations rise in the luteal phase of ovulatory cycles. The authors point out that levels are low after menopause and in men. They suggest this could help explain why high blood pressure and cardiovascular disease in women catch up with rates in men. NaProTechnology protocols use cycle-timed natural progesterone support.

Abstract

In a placebo controlled, double blind crossover study natural progesterone was given by mouth, in increasing doses, to six men and four postmenopausal women with mild to moderate hypertension who were not receiving any other antihypertensive drugs. When compared with values recorded before treatment and during administration of placebo progesterone caused a significant reduction in blood pressure, suggesting that progesterone has an antihypertensive action rather than a hypertensive one as has been previously thought. This possible protective effect of progesterone should be investigated further.

Topics

By this author

Related research

Therapeutics › Hormonal Agents › Progesterone and Progestins
J C De Trafford, Mark Brincat
M Brincat
PMID 3917316 3917316 DOI 10.1136/bmj.290.6461.13 10.1136/bmj.290.6461.13 Rylance et al. 1985, Rylance 1985